In this empirical paper, I am looking at how individuals make reputational judgement of pharmaceutical companies when they prescribe a medicine, and, how the Mediator’s scandal in France has changed rules, material practices and the institutional logic. The literature review explores first the...

BACKGROUND: In 2005, the French Government implemented a new way of financing high-cost drugs for hospitals in order to promote innovation. Such drugs are gathered on a positive list, established by the Ministry of Health, with a reimbursement price cap. Hospitals still negotiate with...

The key role of institutions for economic performance has recently been acknowledged in the economic policy debate. This paper aims at pointing out the main policy lessons and the recommendations to be drawn from New Institutional Economics (NIE), when considering the organization of markets. We...